Eli Lilly | Leverandørgæld



Trade Creditors Lave om Dato
AbbVie 2.94B 2.66B 2024-12
Abbott USD 11.7B 8.8B 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Baxter International USD 968M 127M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Glaxosmithkline 13.47B 1.15B 2024-09
Indivior 50M 4M 2024-09
J&J USD 10.31B 1.36B 2024-12
Medtronic USD 2.29B 90M 2025-01
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prestige Brands USD 19.51M 11.67M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 7.43B 105M 2024-06
Sanofi 7.43B 105M 2024-06
United Therapeutics 6M 357.9M 2024-12
Zoetis USD 433M 29M 2024-12



Eli Lilly Leverandørgæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.